Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

De-activating chromosomes to prevent cancer

Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy
De-activating chromosomes to prevent cancer ( Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy )
21 Jul 2015

New emerging treatments in multiple myeloma

Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe Moreau, Prof Mario Boccadoro
New emerging treatments in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe Moreau, Prof Mario Boccadoro )
7 Jul 2015

Natural killer immunity and the cancer immunome

Dr Angel Porgador - Ben-Gurion University of the Negev, Beer-Sheva, Israel
Natural killer immunity and the cancer immunome ( Dr Angel Porgador - Ben-Gurion University of the Negev, Beer-Sheva, Israel )
6 Jul 2015

What can T-cells see on human cancer?

Prof Ton Schumacher – The Netherlands Cancer Institute, Amsterdam, The Netherlands
What can T-cells see on human cancer? ( Prof Ton Schumacher – The Netherlands Cancer Institute, Amsterdam, The Netherlands )
6 Jul 2015

Moving precision medicine for lung cancer into the adjuvant setting

Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA
Moving precision medicine for lung cancer into the adjuvant setting ( Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA )
6 Jul 2015

WIN Symposium 2015 highlights

Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO)
WIN Symposium 2015 highlights ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
6 Jul 2015

Radiation and immunology – a new therapeutic partnership

Dr Ralph Weichselbaum - University of Chicago, Chicago, USA
Radiation and immunology – a new therapeutic partnership ( Dr Ralph Weichselbaum - University of Chicago, Chicago, USA )
6 Jul 2015

TAT 2016: Targeted anticancer therapies

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA
TAT 2016: Targeted anticancer therapies ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )
19 Jun 2015

Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL

Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands
Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )
17 Jun 2015

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )
16 Jun 2015

Exciting update on the Repurposing Drugs in Oncology (ReDO) project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium
Exciting update on the Repurposing Drugs in Oncology (ReDO) project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )
15 Jun 2015

EHA 2015: Reviewing the treatment landscapes of CLL, MCL, and MM

Prof John Gribben, Prof Marivi Mateos, Prof Umberto Vitolo, Prof Paolo Ghia
EHA 2015: Reviewing the treatment landscapes of CLL, MCL, and MM ( Prof John Gribben, Prof Marivi Mateos, Prof Umberto Vitolo, Prof Paolo Ghia )
14 Jun 2015